Key Points
- The U.S. government reversed its ban on Anthropic’s Mythos 5 system in just 15 days, allowing its redeployment to select federal agencies and over 100 trusted partners.
- This regulatory relief for Anthropic is strategically timed as both Anthropic and OpenAI (OpenAI 开放人工智能) are
targeting public listings in Q3 2026, with government approval reducing IPO uncertainty. - OpenAI’s new GPT-5.6, priced at roughly half the cost of Anthropic’s Claude Fable 5, faces its own regulatory
headwinds, being limited to “trusted partners” after government demonstration. - The shift indicates that artificial intelligence (Rengong Zhineng 人工智能) regulation is becoming more nuanced,
favoring companies that collaborate with regulators for market advantage and approved access.
- June 12, 2026: Initial export control order issued, halting Mythos 5 and Fable 5 access.
- June 15, 2026: Anthropic and OpenAI quietly file S-1 draft registration statements for Q3 IPOs.
- June 27, 2026: U.S. Commerce Dept lifts restrictions for Mythos 5 for approved entities.
- June 27, 2026: OpenAI releases GPT-5.6 (Sol) with strict “trusted partner” limited access.
We’re witnessing a major shift in how the U.S. government approaches artificial intelligence (Rengong Zhineng 人工智能) regulation.
On June 27, 2026, Anthropic announced a significant win: the U.S. government greenlit the redeployment of its Mythos 5 system to select federal agencies managing critical infrastructure.
This isn’t just another regulatory update—it signals a broader policy reversal that could reshape the entire AI landscape as we head into a pivotal moment for tech IPOs.
The Reversal: From Ban to Selective Access in Two Weeks
Here’s the timeline that matters:
- June 12: The U.S. government issued an export control order, forcing Anthropic to halt access to Mythos 5 and Fable 5 for all users.
- June 27: Commerce Secretary Howard Lutnick (Haowade Lutenike 霍华德·卢特尼克) sent a letter to Anthropic lifting restrictions—but with conditions.
The speed of this reversal is telling.
In just 15 days, Anthropic went from complete lockdown to selective reopening.
According to Lutnick’s letter, Anthropic’s collaboration with the government “made significant progress” in addressing risks tied to the regulated models.
Translation: The company find a path forward that satisfied national security concerns while keeping business moving.
Find Top Talent on China's Leading Networks
- Post Across China's Job Sites from $299 / role
- Qualified Applicant Bundles
- One Central Candidate Hub
Your First Job Post Use Checkout Code 'Fresh20'
Who Gets Access? The Approved List Matters Now
Not everyone gets back in the door.
The redeployment comes with clear boundaries:
- Federal agencies: Departments responsible for operating and maintaining critical infrastructure now have access to Mythos 5.
- Over 100 trusted partners: Fortune 500 companies and other vetted institutions are included in the approved pool.
- Foreign employees: Staff at trusted companies and Anthropic’s own international team will no longer need export licenses to use Mythos 5.
- Everyone else: Companies not on the approved list remain locked out.
This creates a two-tier system.
Companies with government approval get full access and competitive advantage.
Companies outside the circle? They’re stuck waiting for the next policy shift.
For startups and mid-market tech firms, this is a critical decision point—getting on that approved list could be the difference between staying competitive and falling behind.
ExpatInvest China
Grow Your RMB in China:
- Invest Your RMB Locally
- Buy & Sell Online in CN¥
- No Lock-In Periods
- English Service & Data
- Start with Only ¥1,000
The IPO Timeline: Why This Matters Right Now
The timing of this regulatory relief isn’t coincidental.
In early June, both Anthropic and OpenAI (OpenAI 开放人工智能) quietly filed S-1 draft registration statements with the Securities and Exchange Commission (SEC).
Both companies are targeting public listings in Q3 2026.
Here’s why the government’s move matters to investors:
- Regulatory clarity: A lifting of restrictions reduces IPO uncertainty and de-risks the investment thesis.
- Revenue visibility: Redeployment to federal agencies opens a new revenue stream—government contracts are stable, long-term, and highly valuable on balance sheets.
- Market confidence: Investors see a company that can work with regulators, not against them. That’s a green flag for institutional buyers.
For Anthropic, this approval is a powerful narrative heading into the roadshow phase of their IPO.
It demonstrates that even during tense regulatory moments, the company maintains government trust and can scale access strategically.
Resume Captain
Your AI Career Toolkit:
- AI Resume Optimization
- Custom Cover Letters
- LinkedIn Profile Boost
- Interview Question Prep
- Salary Negotiation Agent
OpenAI’s Parallel Battle: GPT-5.6 Under Pressure
While Anthropic caught a break, OpenAI faces its own regulatory headwinds.
On the same day as Anthropic’s announcement, OpenAI released GPT-5.6—its newest flagship model series with breakthroughs in programming, cybersecurity (Wangluo Anquan 网络安全), and biology.
The competitive positioning is clear: OpenAI priced GPT-5.6’s flagship model, Sol, at roughly half the cost of Anthropic’s Claude Fable 5.
Here’s the pricing breakdown:
- Anthropic’s Claude Fable 5: ¥71.86 RMB ($10.00 USD) to ¥359.32 RMB ($50.00 USD) per tier
- OpenAI’s GPT-5.6 Sol: Approximately 50% less expensive than the highest Fable 5 tier
It’s a classic market-share play.
But there’s a catch: GPT-5.6 hasn’t had a full public release.
Instead, it’s limited to preview access for “trusted partners”—roughly 20 companies, according to reports.
OpenAI disclosed that it demonstrated the model to the U.S. government before launching and agreed to the government’s request for limited preview access among approved partners.
This is not the aggressive, move-fast-and-break-things energy OpenAI is known for.
It signals that even the world’s most powerful AI labs now operate within tighter regulatory constraints.
What This Means for the AI Industry
The bigger picture here is that artificial intelligence (Rengong Zhineng 人工智能) regulation is becoming more nuanced, not less.
We’re not seeing a blanket deregulation.
Instead, we’re seeing the government create a framework where:
- Advanced AI models can exist and scale—but only within approved channels.
- Companies that collaborate with regulators get market advantage.
- Federal agencies and critical infrastructure get priority access to cutting-edge AI.
- Foreign employees and international access are permitted, but still monitored.
For founders and investors, this creates both opportunity and friction:
- Opportunity: There’s a clear path to scale if you work within the regulatory framework. Anthropic just proved it.
- Friction: You can’t ignore government approval anymore. It’s a prerequisite for growth, not an afterthought.
The companies that figure out how to move quickly with regulators—not against them—will be the ones that win the next generation of AI market share.
The Bottom Line: Regulation Isn’t Slowing Down AI—It’s Reshaping It
If you’re building in the AI space, you need to think about regulatory alignment from day one.
The Anthropic approval and OpenAI restrictions show us that government oversight of artificial intelligence (Rengong Zhineng 人工智能) is real and ongoing, but it’s not necessarily a blocker—it’s a dance.
Companies that can choreograph that dance effectively will access markets and capital faster than those that can’t.
As both Anthropic and OpenAI approach their public listings, watch for how they communicate these regulatory wins and constraints to investors.
It’ll be the story of the IPO cycle.
